Usefulness of Serum High-Density Lipoprotein Cholesterol Level as an Independent Predictor of One-Year Mortality After Percutaneous Coronary Interventions

American Journal of Cardiology

Volumn 103, Issue 7, 2009, Pages 902-906

  Ghazzal, Ziyad B ^a,c   Dhawan, Saurabh S ^a   Sheikh, Abdul ^a   Douglas, John S ^a   Veledar, Emir ^a   Mavromatis, Kreton ^a   Pohlel, F Khan ^a   Vaccarino, Viola ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BYPASS SURGERY; CHOLESTEROL BLOOD LEVEL; DEATH; DIABETES MELLITUS; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; FEMALE; FOLLOW-UP STUDIES; GEORGIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 62849086187     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.11.053     Document Type: Article

References (16)

1. Cole J.H., Miller III J.I., Sperling L.S., and Weintraub W.S. Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol 41 (2003) 521-528
2. Weintraub W.S., Clements Jr. S.D., Crisco L.V.-T., Guyton R.A., Craver J.M., Jones E.L., and Hatcher Jr. C.R. Twenty-year survival after coronary artery surgery: an institutional perspective from Emory University. Circulation 107 (2003) 1271-1277
3. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., and Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256 (1986) 2835-2838
4. Castelli W.P., Doyle J.T., Gordon T., Hames C.G., Hjortland M.C., Hulley S.B., Kagan A., and Zukel W.J. HDL cholesterol and other lipids in coronary heart disease. The Cooperative Lipoprotein Phenotyping Study. Circulation 55 (1977) 767-772
5. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
6. Thompson P., and Bortz II W.M. Significance of high-density lipoprotein cholesterol. J Am Geriatr Soc 26 (1978) 440-442
7. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., Jacobs Jr. D.R., Bangdiwala S., and Tyroler H.A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79 (1989) 8-15
8. Goldenberg I., Goldbourt U., Boyko V., Behar S., Reicher-Reiss H., and Group BIPS. Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention trial). Am J Cardiol 97 (2006) 466-471
9. Okamura T., Hayakawa T., Kadowaki T., Kita Y., Okayama A., Ueshima H., and Group NDR. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis 184 (2006) 143-150
10. Cui Y., Blumenthal R.S., Flaws J.A., Whiteman M.K., Langenberg P., Bachorik P.S., and Bush T.L. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161 (2001) 1413-1419
11. Jacobs Jr. D.R., Mebane I.L., Bangdiwala S.I., Criqui M.H., and Tyroler H.A. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 131 (1990) 32-47
12. Barter P., Gotto A.M., LaRosa J.C., Maroni J., Szarek M., Grundy S.M., Kastelein J.J.P., Bittner V., and Fruchart J.-C. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. for Treating to New Targets I. N Engl J Med 357 (2007) 1301-1310
13. Lundstam U., Herlitz J., Karlsson T., Linden T., and Wiklund O. Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med 251 (2002) 111-118
14. Olsson A.G., Schwartz G.G., Szarek M., Sasiela W.J., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., and Zeiher A. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J 26 (2005) 890-896
15. Grant R.W., and Meigs J.B. Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction. Diabetes Care 30 (2007) 479-484
16. Haffner S.M., and American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 27 suppl 1 (2004) S68-S71